Insider Trading History of Slater Eve Elizabeth

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Slater Eve Elizabeth since 2006. The trader's CIK number is 1289739. At the time of the last reporting, Slater Eve Elizabeth was the Director of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX). Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.

Note that in the past Slater Eve Elizabeth also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Phase Forward Inc (PFWD) by Slater Eve Elizabeth

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 PFWD 1,700 $22,919 0 $0 0 $0

Yearly summary of insider trading at Vertex Pharmaceuticals Inc / Ma (VRTX) by Slater Eve Elizabeth

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 VRTX 0 $0 10,000 $304,200 10,000 $133,200
2006 VRTX 1,105 $37,950 0 $0 0 $0


Insider trading activities at 2 companies by Slater Eve Elizabeth:

1. Phase Forward Inc (PFWD)

2. Vertex Pharmaceuticals Inc / Ma (VRTX)

Table 1. Insider trading of Phase Forward Inc (PFWD) by Slater Eve Elizabeth

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-02-26 PFWD Buy 1,700 13.48 22,919

Table 2. Insider trading of Vertex Pharmaceuticals Inc / Ma (VRTX) by Slater Eve Elizabeth

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-05-29 VRTX Sale 10,000 30.42 304,200
2007-05-29 VRTX Option Ex 10,000 13.32 133,200
2006-05-17 VRTX Buy 455 31.98 14,550
2006-03-23 VRTX Buy 650 36.00 23,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Slater Eve Elizabeth (Director of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.